CEACAM5 and cancer: The classical circulating blood biomarkers for cancer, such as prostate-specific antigen (PSA), carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), alpha-fetoprotein (AFP), etc., are neither sensitive nor specific.